Anthem Blue Cross and Blue Shield Nevada policy
Molecular Signature Test for Predicting Response to Tumor Necrosis Factor Inhibitor Therapy
Molecular Signature Test for Predicting Response to Tumor Necrosis Factor Inhibitor Therapy is a public Anthem Blue Cross and Blue Shield Nevada policy (policy LAB.00042). It lists 1 CPT or HCPCS code, 0 of them on the Anthem Blue Cross and Blue Shield Nevada prior authorization list. Not a coverage decision; the payer's own document governs.
Check eligibility for free
No account required. Sign a BAA to see plan details, coordination of benefits and more
- Policy number
- LAB.00042
- Line of business
- Commercial
- Source
- www.anthem.com
Codes in this policy
The CPT and HCPCS codes the policy names. A policy can name a code it excludes. Prior authorization status is from the Anthem Blue Cross and Blue Shield Nevada prior authorization list.
| Code | Prior authorization | Description on the prior authorization list | Other Anthem Blue Cross and Blue Shield Nevada policies |
|---|---|---|---|
| 81599 | Not listed | Policies naming 81599 |
All Anthem Blue Cross and Blue Shield Nevada policies · Anthem Blue Cross and Blue Shield Nevada prior authorization CPT list